Tuberculosis-induced haemophagocytic syndrome in a patient on haemodialysis treated with anti-thymocyte globulin

Int J Tuberc Lung Dis. 2014 Feb;18(2):248-9. doi: 10.5588/ijtld.13.0533.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antilymphocyte Serum / therapeutic use*
  • Antitubercular Agents / therapeutic use
  • Drug Therapy, Combination
  • Glucocorticoids / therapeutic use
  • Humans
  • Immunologic Factors / therapeutic use*
  • Kidney Failure, Chronic / complications
  • Kidney Failure, Chronic / diagnosis
  • Kidney Failure, Chronic / therapy*
  • Lymphohistiocytosis, Hemophagocytic / diagnosis
  • Lymphohistiocytosis, Hemophagocytic / drug therapy*
  • Lymphohistiocytosis, Hemophagocytic / etiology
  • Lymphohistiocytosis, Hemophagocytic / immunology
  • Lymphohistiocytosis, Hemophagocytic / microbiology
  • Male
  • Mycobacterium tuberculosis / isolation & purification
  • Renal Dialysis*
  • Tomography, X-Ray Computed
  • Treatment Outcome
  • Tuberculosis, Pulmonary / complications*
  • Tuberculosis, Pulmonary / diagnosis
  • Tuberculosis, Pulmonary / drug therapy
  • Tuberculosis, Pulmonary / immunology
  • Tuberculosis, Pulmonary / microbiology
  • Young Adult

Substances

  • Antilymphocyte Serum
  • Antitubercular Agents
  • Glucocorticoids
  • Immunologic Factors